HomeSTOK • NASDAQ
add
Stoke Therapeutics Inc
Previous close
$9.63
Day range
$9.56 - $10.06
Year range
$5.35 - $17.58
Market cap
532.87M USD
Avg Volume
846.83K
P/E ratio
12.40
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 158.57M | 3,661.12% |
Operating expense | 47.33M | 45.23% |
Net income | 112.88M | 527.99% |
Net profit margin | 71.19 | 111.38% |
Earnings per share | 1.90 | 433.33% |
EBITDA | 111.72M | 501.73% |
Effective tax rate | 1.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 357.32M | 100.09% |
Total assets | 406.89M | 98.31% |
Total liabilities | 56.81M | -12.38% |
Total equity | 350.07M | — |
Shares outstanding | 54.60M | — |
Price to book | 1.50 | — |
Return on assets | 81.98% | — |
Return on capital | 94.58% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 112.88M | 527.99% |
Cash from operations | 131.83M | 636.62% |
Cash from investing | 13.63M | 36.48% |
Cash from financing | 1.37M | -19.98% |
Net change in cash | 146.83M | 1,241.69% |
Free cash flow | 78.85M | 1,110.81% |
About
Founded
2014
Headquarters
Website
Employees
128
